Teglicar

Teglicar

Cat. No.: DIA-0243225

Size: 10 mg Size: 25 mg Size: 50 mg Size: 100 mg Size: Customer Size
Product Information
CAS No. 250694-07-6
Formula C22H45N3O3
Molecular Weight 399.61
SMILES O=C(N[C@H](CC([O-])=O)C[N+](C)(C)C)NCCCCCCCCCCCCCC
Target Endogenous Metabolite
Product Description Teglicar is a selective and reversible orally active liver isoform of carnitine palmitoyl-transferase 1 (L-CPT1) inhibitor with an IC50 value of 0.68 μM and a Ki value of 0.36 μM. Teglicar has a potential antihyperglycemic propert. Teglicar can be used for the research of diabetes and neurodegenerative disease including Huntington's disease (HD).
Format & Storage
Format Solid
Color White to off-white
Purity ≥98.0%
Shipping Room temperature in the continental U.S. Other areas may vary.
Storage Powder: -20°C, 3 years; 4°C, 2 years In solvent: -80°C, 6 months; -20°C, 1 month
Solubility Overview Ethanol : 100 mg/mL DMSO : 19 mg/mL H2O : 10 mg/mL
All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
logo

Ace Therapeutics has a team of wellknown experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.

Quick Links
Contact Info
Copyright © Ace Therapeutics. All Rights Reserved.
Top